Antimicrobial use, drug-resistant infections and COVID-19

Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing

(2020) Timothy M Rawson et al.   CLINICAL INFECTIOUS DISEASES

A real-world evaluation of a Case-Based Reasoning algorithm to support antimicrobial prescribing decisions in acute care

(2020) Timothy M Rawson et al.   CLINICAL INFECTIOUS DISEASES

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

(2020) Philippe Gautret et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

COVID-19 and the potential long-term impact on antimicrobial resistance

(2020) Timothy M Rawson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Virtually Perfect? Telemedicine for Covid-19

(2020) Judd E. Hollander et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020

(2020) Jeanne M. Santoli et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe

(2018) Mike Sharland et al.   LANCET INFECTIOUS DISEASES

Antimicrobial stewardship: are we failing in cross-specialty clinical engagement?

(2015) Timothy M. Rawson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY